Vascular endothelium: target or victim of cytostatic therapy?

By Romanov Yuri A.   Chervontseva Alevtina M.   Savchenko Valery G.   Smirnov Vladimir N.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 3-4, 2007-03 ,pp. : 396-403

NRC Research Press

Access to resources Recommend Favorite

New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery

By Saxena Uday   Timmer Richard T   Pillarisetti Sivaram  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 539-545

Informa Healthcare

Access to resources Recommend Favorite

Early Vascular Aging: A New Target for Hypertension Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 1, 2016-01 ,pp. : 122-126

Bentham Science Publishers

Access to resources Recommend Favorite

Sex-Gender Differences in Diabetes Vascular Complications and Treatment

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 2, 2012-06 ,pp. : 179-196

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon as a target for the treatment of Type 2 diabetes

By Sloop Kyle W   Michael M Dodson   Moyers Julie S  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite